FAST and ASF Announce their Partnership with the Institute for Gene Therapies
ASF and FAST partner with the Institute for Gene Therapies to push for policy changes that ensure patients can access cutting-edge gene therapies for Angelman syndrome.
ASF and FAST partner with the Institute for Gene Therapies to push for policy changes that ensure patients can access cutting-edge gene therapies for Angelman syndrome.
Find information on Angelman syndrome, research, clinical trials, resources, and ways to get involved.